BackAIM ImmunoTech Overview

AIM ImmunoTech Accounts Payable

Track AIM ImmunoTech's accounts payable ($480K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$480000.00
93.42% YoYΔ $-6.82M vs prior year quarter

Peer trimmed avg / median

Loading

AIM ImmunoTech Accounts Payable History

Loading

AIM ImmunoTech vs. peers: Accounts Payable Comparison

Loading

AIM ImmunoTech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AIM ImmunoTech (AIM) FAQ

The latest accounts payable for AIM is $480K as of June 2026. That compares with $7.3M in the prior-year period — down 93.4% year over year. Investors often review this figure alongside AIM ImmunoTech's historical trend and sector peers before judging valuation or financial health.

Over the past year, AIM's accounts payable moved from $7.3M to $480K — a 93.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AIM ImmunoTech's operating scale or balance-sheet position.

A accounts payable figure of $480K for AIM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AIM's accounts payable ($480K), review year-over-year change from $7.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AIM ImmunoTech's accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.